Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Mezzanine Equity and Shareholders??? Equity (Capital Deficiency) (Unaudited)

v3.24.2.u1
Consolidated Statements of Mezzanine Equity and Shareholders’ Equity (Capital Deficiency) (Unaudited) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Warrants To Placement Agent
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2022 $ 1 $ 36,666 $ (33,402) $ 3,265
Balance (in Shares) at Dec. 31, 2022     1,737,986      
Share based compensation   192 192
Share based compensation (in Shares)            
Repurchase of common stock [1] (50) (50)
Repurchase of common stock (in Shares)     (7,920)      
Issuance of common stock and pre-funded warrants upon private placement, net of offering costs 104 [1] 1,356 1,356
Issuance of common stock and pre-funded warrants upon private placement, net of offering costs (in Shares)     190,000        
Exercise of options into common stock [1] 10 10
Exercise of options into common stock (in Shares)     10,652        
Net comprehensive loss for the period   (3,488) (3,488)
Net comprehensive loss for the period (in Shares)            
Balance at Jun. 30, 2023 104 $ 1 38,174 (36,890) 1,285
Balance (in Shares) at Jun. 30, 2023   1,930,718      
Balance at Mar. 31, 2023   $ 1 36,711 (35,297) 1,415
Balance (in Shares) at Mar. 31, 2023   1,730,066      
Share based compensation   97   97
Issuance of common stock and pre-funded warrants upon private placement, net of offering costs   104 [1] 1,356 1,356
Issuance of common stock and pre-funded warrants upon private placement, net of offering costs (in Shares)     190,000        
Exercise of options into common stock   [1] 10 10
Exercise of options into common stock (in Shares)     10,652        
Net comprehensive loss for the period   (1,593) (1,593)
Balance at Jun. 30, 2023 104 $ 1 38,174 (36,890) 1,285
Balance (in Shares) at Jun. 30, 2023   1,930,718      
Balance at Dec. 31, 2023 159 $ 1 39,916 (39,688) 229
Balance (in Shares) at Dec. 31, 2023     3,007,745      
Share based compensation         179   179
Exercise of options into common stock     [1]   32   $ 32
Exercise of options into common stock (in Shares)     21,225       21,225
Vesting of RSUs   [1]
Vesting of RSUs (in Shares)     18,495        
Warrant inducement agreement, net of offering costs (Note 7d) 42 [1]   2,560   2,560
Warrant inducement agreement, net of offering costs (Note 7d) (in Shares)     999,670        
Exercise of Pre funded warrants into common stock (Note 7b) [1]            
Exercise of Pre funded warrants into common stock (Note 7b) (in Shares)     970,187        
Net comprehensive loss for the period       (2,064) (2,064)
Balance at Jun. 30, 2024 201 $ 1 42,687 (41,752) 936
Balance (in Shares) at Jun. 30, 2024   5,017,322      
Balance at Mar. 31, 2024   159 $ 1 40,005 (41,674) (1,668)
Balance (in Shares) at Mar. 31, 2024   3,010,244      
Share based compensation   90   90
Exercise of options into common stock       32 32
Exercise of options into common stock (in Shares)     21,225        
Vesting of RSUs   [1]
Vesting of RSUs (in Shares)     15,996        
Warrant inducement agreement, net of offering costs (Note 7d)   42 2,560 2,560
Warrant inducement agreement, net of offering costs (Note 7d) (in Shares)     999,670        
Exercise of Pre funded warrants into common stock (Note 7b)     [1]     [1]
Exercise of Pre funded warrants into common stock (Note 7b) (in Shares)     970,187        
Net comprehensive loss for the period       (78) (78)
Balance at Jun. 30, 2024 $ 201 $ 1 $ 42,687 $ (41,752) $ 936
Balance (in Shares) at Jun. 30, 2024   5,017,322      
[1] Represents an amount less than $1 thousands.